What does CUSIP 230770109 represent in this 13F holders report?

CUSIP 230770109 is the security identifier for CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock used to aggregate holder disclosures.

How many institutions held CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock in Q3 2018?

30 institutional investors reported CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock for Q3 2018. Use the holders table for investor-level position and value details.

CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)

CUSIP: 230770109

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class: Equity / Common stock
Shares outstanding: 15,075,924
Total 13F shares: 5,355,808
Share change: -5,955
Total reported value: $30,579,000
Price per share: $5.71
Number of holders: 30
Value change: -$33,832
Number of buys: 13
Number of sells: 6

Quarterly Holders Quick Answers

What is CUSIP 230770109?
CUSIP 230770109 identifies CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2018
Previous quarter: Q2 2018

Recent filing periods for CUSIP 230770109:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ARIEL INVESTMENTS, LLC	13F	Company	8.7%	1,305,052	$8,000,000	—	30 Jun 2018	13F
Stonepine Capital Management, LLC	13F	Company	8%	1,203,339	$7,376,000	—	30 Jun 2018	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	5.8%	872,674	$5,349,000	—	30 Jun 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	2.5%	377,209	$2,312,000	—	30 Jun 2018	13F
BlackRock Finance, Inc.	13F	Company	2.2%	330,318	$2,024,000	—	30 Jun 2018	13F
VANGUARD GROUP INC	13F	Company	2.1%	313,764	$1,923,000	—	30 Jun 2018	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	1.7%	260,730	$1,598,000	—	30 Jun 2018	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	1.4%	205,400	$1,259,000	—	30 Jun 2018	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.72%	108,486	$664,000	—	30 Jun 2018	13F
BARD ASSOCIATES INC	13F	Company	0.53%	79,615	$488,000	—	30 Jun 2018	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.36%	53,800	$330,000	—	30 Jun 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.32%	48,610	$297,000	—	30 Jun 2018	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.2%	29,700	$182,000	—	30 Jun 2018	13F
NORTHERN TRUST CORP	13F	Company	0.16%	24,429	$150,000	—	30 Jun 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.16%	23,709	$145,000	—	30 Jun 2018	13F
Bank of New York Mellon Corp	13F	Company	0.13%	20,338	$125,000	—	30 Jun 2018	13F
MORGAN STANLEY	13F	Company	0.13%	19,233	$118,000	—	30 Jun 2018	13F
UNITED CAPITAL FINANCIAL ADVISORS, LLC	13F	Company	0.11%	16,626	$102,000	—	30 Jun 2018	13F
STATE STREET CORP	13F	Company	0.09%	13,490	$82,000	—	30 Jun 2018	13F
DELTA ASSET MANAGEMENT LLC/TN	13F	Company	0.07%	11,000	$67,000	—	30 Jun 2018	13F
Spark Investment Management LLC	13F	Company	0.07%	10,800	$66,000	—	30 Jun 2018	13F
Cambridge Investment Research Advisors, Inc.	13F	Company	0.07%	10,000	$61,000	—	30 Jun 2018	13F
Ballew Advisors, Inc	13F	Company	0.04%	5,600	$34,000	—	30 Jun 2018	13F
Russell Investments Group, Ltd.	13F	Company	0.03%	5,198	$32,000	—	30 Jun 2018	13F
MACQUARIE GROUP LTD	13F	Company	0.03%	4,100	$25,000	—	30 Jun 2018	13F
SEI INVESTMENTS CO	13F	Company	0.03%	3,808	$23,000	—	30 Jun 2018	13F
Oakworth Capital, Inc.	13F	Company	0.02%	3,052	$19,000	—	30 Jun 2018	13F
UBS Group AG	13F	Company	0.02%	2,822	$17,000	—	30 Jun 2018	13F
Tower Research Capital LLC (TRC)	13F	Company	0.02%	2,669	$16,000	—	30 Jun 2018	13F

Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) as of Q3 2018

As of 30 Sep 2018, CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,355,808 shares. The largest 10 holders included ARIEL INVESTMENTS, LLC, Stonepine Capital Management, LLC, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., Vanguard Group Inc, NEW YORK STATE COMMON RETIREMENT FUND, BRIDGEWAY CAPITAL MANAGEMENT INC, ACADIAN ASSET MANAGEMENT LLC, and BARD ASSOCIATES INC. This page lists 30 institutional shareholders reporting positions in this security for the Q3 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2018 vs Q2 2018 Across Filers

Q2 2018 holders

Q3 2018 holders

Holder diff

Investor	Q2 2018 Shares	Q3 2018 Shares	Share Diff	Share Chg %	Q2 2018 Value $	Q3 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.